2017
DOI: 10.1038/nn.4541
|View full text |Cite
|
Sign up to set email alerts
|

Cell transplantation therapy for spinal cord injury

Abstract: Spinal cord injury can lead to severe motor, sensory and autonomic dysfunction. Currently, there is no effective treatment for the injured spinal cord. The transplantation of Schwann cells, neural stem cells or progenitor cells, olfactory ensheathing cells, oligodendrocyte precursor cells and mesenchymal stem cells has been investigated as potential therapies for spinal cord injury. However, little is known about the mechanisms through which these individual cell types promote repair and functional improvement… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

4
607
0
3

Year Published

2018
2018
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 647 publications
(614 citation statements)
references
References 148 publications
4
607
0
3
Order By: Relevance
“…Despite immunosuppression using the combination of three agents, hWJ‐MSCs did not survive in the host tissue over the period of 8 weeks. On the other hand, we proved the effect of the cells using immunohistochemical and qPCR analysis, which supports the commonly proposed hypothesis that transplanted cells release trophic factors that provide long lasting neurotrophic and immunomodulatory effects …”
Section: Discussionsupporting
confidence: 86%
“…Despite immunosuppression using the combination of three agents, hWJ‐MSCs did not survive in the host tissue over the period of 8 weeks. On the other hand, we proved the effect of the cells using immunohistochemical and qPCR analysis, which supports the commonly proposed hypothesis that transplanted cells release trophic factors that provide long lasting neurotrophic and immunomodulatory effects …”
Section: Discussionsupporting
confidence: 86%
“…1,2 The current therapeutic strategies of SCI are not sufficient because of the failure of axonal and neural regrowth. 1,2 The current therapeutic strategies of SCI are not sufficient because of the failure of axonal and neural regrowth.…”
Section: Discussionmentioning
confidence: 99%
“…1 A serious of early-phase clinical trials have proven the potentially of the stem cell transplantation as a feasible strategy to repair the neural circuit after SCI. insufficient to reconstruct the interruption of neuroanatomical circuits.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…The most obvious finding to emerge from our analyses was that in rats with SCI, iPSC transplantation significantly promotes the locomotor recovery according to the BBB score. A possible explanation for this might be that iPSC are one of the most widely used cell types for transplantation performed to recover the functions impaired as a result of injury [32]. In addition, the mechanism by which iPSC transplantation mediated functional improvements after SCI is multifaceted [33][34][35] although it is commonly accepted that iPSC transplantation can [7]: 1) reduce the area of syringomyelia and increase the area of spared tissue; 2) promote local microvascular regeneration and nerve regeneration for the repair of damaged cells; 3) reduce inflammation and inhibit oxidative stress after SCI; and 4) improve axonal growth and reconstruction of neural pathways by secreting substrates.…”
Section: Discussionmentioning
confidence: 99%